JP2003515543A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003515543A5 JP2003515543A5 JP2001541010A JP2001541010A JP2003515543A5 JP 2003515543 A5 JP2003515543 A5 JP 2003515543A5 JP 2001541010 A JP2001541010 A JP 2001541010A JP 2001541010 A JP2001541010 A JP 2001541010A JP 2003515543 A5 JP2003515543 A5 JP 2003515543A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- halogen
- compound according
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL99204080.8 | 1999-12-02 | ||
| EP99204080 | 1999-12-02 | ||
| PCT/EP2000/012009 WO2001040255A2 (en) | 1999-12-02 | 2000-11-29 | 14,15-beta-methylene substituted androgens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003515543A JP2003515543A (ja) | 2003-05-07 |
| JP2003515543A5 true JP2003515543A5 (enExample) | 2008-01-10 |
Family
ID=8240955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001541010A Pending JP2003515543A (ja) | 1999-12-02 | 2000-11-29 | １４，１５−ベータ−メチレン置換されたアンドロゲン |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6706700B2 (enExample) |
| EP (1) | EP1237904B1 (enExample) |
| JP (1) | JP2003515543A (enExample) |
| CN (1) | CN1166680C (enExample) |
| AR (1) | AR026655A1 (enExample) |
| AT (1) | ATE317396T1 (enExample) |
| AU (1) | AU778017B2 (enExample) |
| CA (1) | CA2390226A1 (enExample) |
| CO (1) | CO5251441A1 (enExample) |
| CY (1) | CY1106086T1 (enExample) |
| CZ (1) | CZ301376B6 (enExample) |
| DE (1) | DE60025958T2 (enExample) |
| DK (1) | DK1237904T3 (enExample) |
| ES (1) | ES2258037T3 (enExample) |
| HK (1) | HK1047596B (enExample) |
| HU (1) | HUP0203611A3 (enExample) |
| IL (1) | IL149424A (enExample) |
| MX (1) | MXPA02004939A (enExample) |
| NO (1) | NO322422B1 (enExample) |
| NZ (1) | NZ518753A (enExample) |
| PE (1) | PE20011033A1 (enExample) |
| PL (1) | PL202999B1 (enExample) |
| RU (1) | RU2242479C2 (enExample) |
| SK (1) | SK287095B6 (enExample) |
| TW (1) | TWI275593B (enExample) |
| WO (1) | WO2001040255A2 (enExample) |
| ZA (1) | ZA200203536B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5209600A (en) * | 1999-04-06 | 2000-10-23 | Akzo Nobel N.V. | Orally active androgens |
| RS51490B (sr) * | 2002-01-21 | 2011-04-30 | N.V. Organon | POSTUPAK ZA IZRADU 7α-METILSTEROIDA |
| US20080293683A1 (en) * | 2007-05-24 | 2008-11-27 | University Of Kansas Medical Center | Hormone Replacement Therapy |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| PL2764008T3 (pl) * | 2011-10-07 | 2017-04-28 | Estetra S.P.R.L. | Sposób wytwarzania estetrolu |
| JP6863547B2 (ja) | 2015-06-18 | 2021-04-21 | エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ | エステトロール成分を含有する口腔内崩壊性投与単位 |
| JP6866560B2 (ja) | 2015-06-18 | 2021-04-28 | エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ | エステトロール成分を含有する口腔内崩壊性投与単位 |
| MA44206B1 (fr) | 2015-06-18 | 2021-04-30 | Estetra Sprl | Comprimé orodispersible comprenant estetrol |
| LT3310345T (lt) | 2015-06-18 | 2021-06-25 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| CN111621141B (zh) * | 2020-06-12 | 2022-04-08 | 广西大学 | 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3086027A (en) * | 1960-01-22 | 1963-04-16 | Lilly Co Eli | 19-nor-4, 9(10)-steroids and process |
| IE60780B1 (en) | 1987-01-23 | 1994-08-10 | Akzo Nv | New 11-aryl steroid derivatives |
| DE19537626A1 (de) * | 1995-10-10 | 1997-04-17 | Jenapharm Gmbh | Steroide mit einer 14, 15-Methylengruppe |
| DE19827522A1 (de) * | 1998-06-22 | 1999-12-23 | Jenapharm Gmbh | 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
| WO2000053619A1 (en) * | 1999-03-08 | 2000-09-14 | Akzo Nobel N.V. | 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
-
2000
- 2000-11-29 PL PL355689A patent/PL202999B1/pl not_active IP Right Cessation
- 2000-11-29 JP JP2001541010A patent/JP2003515543A/ja active Pending
- 2000-11-29 AU AU28383/01A patent/AU778017B2/en not_active Ceased
- 2000-11-29 HU HU0203611A patent/HUP0203611A3/hu unknown
- 2000-11-29 RU RU2002117440/04A patent/RU2242479C2/ru not_active IP Right Cessation
- 2000-11-29 HK HK02109169.4A patent/HK1047596B/en not_active IP Right Cessation
- 2000-11-29 NZ NZ518753A patent/NZ518753A/en unknown
- 2000-11-29 AT AT00993259T patent/ATE317396T1/de not_active IP Right Cessation
- 2000-11-29 CZ CZ20021894A patent/CZ301376B6/cs not_active IP Right Cessation
- 2000-11-29 MX MXPA02004939A patent/MXPA02004939A/es active IP Right Grant
- 2000-11-29 DE DE60025958T patent/DE60025958T2/de not_active Expired - Lifetime
- 2000-11-29 IL IL149424A patent/IL149424A/en not_active IP Right Cessation
- 2000-11-29 EP EP00993259A patent/EP1237904B1/en not_active Expired - Lifetime
- 2000-11-29 US US10/148,820 patent/US6706700B2/en not_active Expired - Fee Related
- 2000-11-29 ES ES00993259T patent/ES2258037T3/es not_active Expired - Lifetime
- 2000-11-29 DK DK00993259T patent/DK1237904T3/da active
- 2000-11-29 SK SK758-2002A patent/SK287095B6/sk not_active IP Right Cessation
- 2000-11-29 CA CA002390226A patent/CA2390226A1/en not_active Abandoned
- 2000-11-29 WO PCT/EP2000/012009 patent/WO2001040255A2/en not_active Ceased
- 2000-11-29 CN CNB008164959A patent/CN1166680C/zh not_active Expired - Fee Related
- 2000-11-30 AR ARP000106304A patent/AR026655A1/es active IP Right Grant
- 2000-12-01 CO CO00092012A patent/CO5251441A1/es not_active Application Discontinuation
- 2000-12-01 PE PE2000001285A patent/PE20011033A1/es not_active Application Discontinuation
- 2000-12-02 TW TW089125707A patent/TWI275593B/zh not_active IP Right Cessation
-
2002
- 2002-05-03 ZA ZA200203536A patent/ZA200203536B/en unknown
- 2002-05-30 NO NO20022564A patent/NO322422B1/no not_active IP Right Cessation
-
2006
- 2006-04-10 CY CY20061100500T patent/CY1106086T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003515543A5 (enExample) | ||
| CA2467222A1 (en) | Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy | |
| JP2007535922A5 (enExample) | ||
| BRPI0512991A (pt) | uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto | |
| EP1731157A3 (en) | Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol | |
| MY126960A (en) | Administration of non-oral androgenic steroids to women | |
| WO2011049948A4 (en) | Neuroprotection and myelin repair using nestorone® | |
| EP2108652A3 (en) | Process for the preparation of drospirenone | |
| RU96115774A (ru) | Производные 11-(замещенный фенил)-эстра-4,9-диена | |
| RU2002117440A (ru) | Новые андрогены | |
| EP1571153A3 (en) | A process for the preparation of drospirenone | |
| CA2467237A1 (en) | Method of preventing or treating benign gynaecological disorders | |
| JP2010507685A5 (enExample) | ||
| RU2002103883A (ru) | Перорально активные андрогены | |
| JP2008512426A5 (enExample) | ||
| JP2006507311A5 (enExample) | ||
| WO2008089093A3 (en) | Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone | |
| WO2005077968A8 (en) | 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity | |
| JP2002540119A5 (enExample) | ||
| WO2001040255A3 (en) | 14,15-beta-methylene substituted androgens | |
| IL164159A0 (en) | C-17 spirolactonization and 6,7 oxidation of steroids | |
| JP2000169325A5 (enExample) | ||
| HUP9903747A2 (hu) | Új eljárás mometazon-furoát előállítására | |
| JP2002539135A5 (enExample) | ||
| WO1999045886A3 (en) | New contraceptive kit for monotherapy |